about
The role of CD95 and CD95 ligand in cancerCD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cellsThe cleaved FAS ligand activates the Na(+)/H(+) exchanger NHE1 through Akt/ROCK1 to stimulate cell motilityFas-Fas Ligand: Checkpoint of T Cell Functions in Multiple SclerosisCD95 and CD95L promote and protect cancer stem cellsEarly protective role of MST1 knockdown in response to experimental diabetic nephropathyAPG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesis.CD95 ligand induces senescence in mismatch repair-deficient human colon cancer via chronic caspase-mediated induction of DNA damage.Necroptosis: A new way of dying?DICE: A novel tumor surveillance mechanism-a new therapy for cancer?RIP1 negatively regulates basal autophagic flux through TFEB to control sensitivity to apoptosisBasal autophagy is negatively regulated by RIP1.Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanismInduction of DISE in ovarian cancer cells in vivo.Identification of DISE-inducing shRNAs by monitoring cellular responses.Small interfering RNAs based on huntingtin trinucleotide repeats are highly toxic to cancer cells.DISE: A Seed-Dependent RNAi Off-Target Effect That Kills Cancer Cells.6mer seed toxicity in tumor suppressive microRNAs
P2860
Q26995847-E467CA4E-B9EA-4BC8-8729-9599DE7C51E2Q27329081-4E72BD54-0F2A-4190-AACD-8B59052F6ED9Q27339583-E06EB284-226E-4C95-9790-7F1C0FD1BA37Q28074658-EBA41811-1092-4ABD-979B-6D344C19659FQ35562681-4407FB40-A6E9-47F9-841D-E6B01C44E65EQ36878561-384E91A1-D2BD-498E-8492-96738BA17A98Q37046747-8D19E8B0-AEC4-43F7-A7EF-E167DD4DEEF3Q37745587-624E1A51-6EDF-46F9-9E70-C881D0CDC861Q38559586-C0267BD5-CCA4-4DCC-BD8F-09AC3890EC43Q40464867-BB6F8F47-E6FB-4081-8AF0-A21C4C86AC8AQ42432087-36E71F7A-7C3A-4EA4-B170-15BC8B4E5A07Q42480925-82177DA1-7B47-4062-A4CF-9627134639FCQ42637848-06D83309-17F0-45C8-A907-A6918A13710BQ47095279-4455BC48-C367-486A-8B48-5616EB36680BQ47675158-9FF2364D-0C16-409B-869F-EB5684DFC983Q50027519-EEEE666D-2A9D-4672-8826-7243F117776EQ50138597-C488B0F8-7FF8-4051-B150-3F65E383BD79Q58105685-B8C0B186-04A9-46A3-AEB0-ADF2D0D7860F
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Death induced by CD95 or CD95 ligand elimination.
@ast
Death induced by CD95 or CD95 ligand elimination.
@en
type
label
Death induced by CD95 or CD95 ligand elimination.
@ast
Death induced by CD95 or CD95 ligand elimination.
@en
prefLabel
Death induced by CD95 or CD95 ligand elimination.
@ast
Death induced by CD95 or CD95 ligand elimination.
@en
P2093
P2860
P1433
P1476
Death induced by CD95 or CD95 ligand elimination.
@en
P2093
Abbas Hadji
Andrea E Murmann
Annika Hau
Bhavneet Bhinder
Hakim Djaballah
Joanne Richards
Navdeep Chandel
Paolo Ceppi
Piotre Kolesza
Shirley De Chant
P2860
P304
P356
10.1016/J.CELREP.2014.02.035
P577
2014-03-20T00:00:00Z